As the health sector evolves post-pandemic, M&A activity is expected to increase due to consolidation and cross-border activity. Companies are looking for ways to improve patient care, boost revenues and market share.
Executing deals in a heavily regulated sector such as healthcare can be complicated. Companies require guidance on everything from valuation setting and due diligence processes to negotiations and intellectual property issues. They also often need help understanding a potential target’s supply chain contracts, employee obligations, and pension and benefit requirements.
Osler’s Health Industry team has the deep knowledge needed to help health companies successfully transact in this changing sector. We often advise on the business opportunities and operational challenges in the healthcare M&A space. We have worked with hospitals, long-term care facilities, private equity firms, medical cannabis companies and software start-ups.
As the healthcare sector continues to innovate, Osler can provide strategic advice to your organization on M&A opportunities.